Elbit Imaging 2025: The Residential Pipeline Is Real, but Value Is Still Stuck Between Financing, Permits, and Partners

Introduction to the Company

Elbit Imaging in 2025 is no longer just a public shell carrying legacy baggage. It is now a residential development platform that was built quickly through two sharp moves: 18 urban renewal projects were injected into the company on December 31, 2024, and Elbit Megoorim was acquired in full on January 15, 2025. A superficial reader can get stuck on the headline numbers, revenue of NIS 37.7 million and a net loss of NIS 5.4 million, and conclude that this is still a small and underpowered story. That is incomplete. What was built here is a project engine that is far larger than what has already reached reported revenue.

What is working now? The balance sheet already looks like the balance sheet of a developer rather than an empty box. Total assets jumped from NIS 72.1 million to NIS 381.4 million in a year, equity rose to NIS 86.9 million, and the fourth quarter already showed that operations are beginning to reach the accounting layer: revenue of NIS 14.2 million, gross profit of NIS 3.3 million, and operating profit of NIS 2.0 million. In its January 2026 investor presentation, management describes a portfolio of 19 projects and 4,616 housing units, with expected apartment-sale revenue of NIS 5.573 billion, unrecognized gross profit of NIS 1.116 billion, and expected surplus of NIS 1.256 billion, all on the company-share basis.

So where is the bottleneck? Not in building a pipeline, but in converting that pipeline into something financeable, executable, and ultimately cash generative. A large part of the economics still sits in equity-accounted projects, in developments that have not yet passed all permit gates, or in project surpluses that are subordinate to banks and bond collateral structures. That is why the right question here is not “how much embedded profit is shown in the deck,” but how much of it will turn into reported earnings, released surplus, and shareholder-accessible cash over the next 2 to 4 quarters.

There is also a clear actionability constraint. Based on the latest market data, the stock traded at 476.4 agorot, which together with 15.7 million shares outstanding implies a market cap of roughly NIS 75 million. The last daily trading turnover was only about NIS 231 thousand, while short interest was effectively nonexistent. In other words, even if the thesis improves, price discovery may remain slow, noisy, and not very liquid.

The right way to orient yourself is not by “consolidated” versus “unconsolidated,” but by three economic layers:

| Layer | What is already working | What is still unresolved | Why it matters | |-----|------|-------| | Projects already reaching the P&L | Efrat, Shahamon, and later additional projects moving into execution | The revenue base is still too small relative to corporate overhead | This is the layer that determines whether the company looks like a real developer in the income statement | | Equity-accounted projects and partner structures | Ben Shemen, Kiryat Bialik, Nofei Ilan, Lev Hasharon, and the Eilat field projects | The company’s economics are lower than the project-level numbers, and cash only rises after partners, banks, and pledges are paid through | This is the layer that is easiest to overstate in theory and hardest to convert into clean cash | | Urban renewal and future pipeline | Lod, Beit Shemesh, Jerusalem, Ashkelon, Haifa, and others | Signatures, permits, financing, and sometimes related-party transactions and dilution | This is where most of the option value sits, but also where most of the timing and funding risk lives |

This chart explains the core story. The future heart of the company already looks more like a broad urban renewal platform than a narrow near-term builder. That expands the option value, but it also lengthens the path to cash.

Events and Triggers

The year the company changed identity

The 2025 report is the first report in which the strategic reset is fully visible. The injection of 18 urban renewal projects from controlling shareholders at the end of 2024 created the initial activity base. The acquisition of Elbit Megoorim on January 15, 2025 added classic greenfield residential development, with land, contractors, sales, and project financing lines.

This was not cosmetic. The company only returned to the TASE main list on July 13, 2025 after that process was completed. Anyone still reading Elbit Imaging mainly through the lens of its past is missing the fact that the business model has already changed at the root.

The expansion in the balance sheet shows both the upside of the transition and the price paid for it. Assets rose sharply, liabilities rose even faster, and equity rose much more modestly. That means the company is indeed building a platform, but it is building it with leverage.

The market should not focus only on the annual report

The critical trigger of 2025 and early 2026 is not another P&L line. It is the financing architecture. Series Y bonds totaling NIS 60 million were issued in August 2025. In February 2026 the company raised another NIS 12 million in equity and NIS 67.5 million in Series XI bonds. The board report explicitly says the new financing was used to replace expensive project-level borrowing and to inject equity into projects moving into bank financing.

That is a real improvement, but not a one-directional one. On the positive side, public debt extended duration and lowered part of the cost of capital. On the negative side, it also tied specific project surpluses to bondholders and made the route to free cash more layered. Series Y relies on Efrat and Ben Shemen surplus. Series XI relies on Afula and Herzog 3 surplus. That is the key point. The company improved its ability to move projects forward, but it also increased the gap between value created at project level and value that is actually free to common shareholders.

The practical near-term triggers sit in Afula, Herzog 3, and Bialik

On February 3, 2026, the company signed financing for Phase A of Park Tzameret in Afula. The maximum facilities and guarantees reach NIS 297 million, but the money does not simply open on its own. Before the first draw, the company must, among other things, repay a NIS 6 million loan to Elbit Megoorim, begin construction by May 30, 2026, receive all permits and approvals, presell at least 40 units for NIS 71.4 million, and contribute NIS 35.8 million of equity, which only falls to NIS 25.6 million after 91 unit sales and 25% completion. These are exactly the types of checkpoints the market will test in the next reports.

On February 12, 2026, Herzog 3 in Bat Yam received a full building permit. It is a small project relative to the wider portfolio, 53 apartments and expected revenue of NIS 86 million, but it matters for another reason: the company says the permit is one of the conditions for releasing part of the Series XI bond proceeds. So the permit is not just operational news. It is also a financing key.

Kiryat Bialik is more complicated still. In January 2026 the partner raised roughly NIS 120 million of bond debt against the full project surplus, and the company said it would therefore not expand its own Series Y for that project. In March 2026, the financing agreement was amended so the project would be split into three phases, with cash facilities up to NIS 260.8 million and Sale Law guarantees rising up to NIS 633 million once conditions are met. But Phase B is still contingent on NIS 277.8 million of presales by March 31, 2026. So the financing map is better, but it also reminds you that even a project that already looks “on the way” still depends on presales and permits.

Efficiency, Profitability, and Competition

The central number in 2025 is a paradox: the company has a very large pipeline and a broad portfolio, but the consolidated income statement is still small. Revenue was NIS 37.7 million, cost of sales NIS 26.8 million, and gross profit NIS 10.9 million. That is enough to show the engine is working, but not enough to carry NIS 11.5 million of G&A, NIS 1.8 million of selling expenses, and NIS 0.9 million of development costs on urban renewal projects that have not yet crossed the recognition threshold.

The chart makes the real issue clear. This is not a case of zero gross profit. It is a case of a platform that already costs like a full developer while only a small part of the portfolio is yet large enough to pay for that platform in the reported accounts.

What actually drove 2025

Most of fourth-quarter revenue came from Efrat, roughly NIS 8 million, and Shahamon Eilat, roughly NIS 5 million. That matters because it shows that revenue is already coming from actual project execution, not from revaluation noise, and not only from promises. At the same time, the group’s share in equity-accounted results amounted to only NIS 124 thousand, a number that looks negligible but actually hides a large gap between projects.

Nofei Ilan contributed about NIS 2.3 million of profit to the company’s share. On the other hand, Ben Shemen dragged through a NIS 2.8 million share of loss, and Kiryat Bialik contributed another roughly NIS 0.9 million loss. In other words, even within the pipeline that is already moving, not every project is at the same economic stage. Some are already contributing, while others are still on the wrong side of the learning curve, carrying heavy financing and yet-to-mature inventory.

Growth quality is less clean than the first read suggests

The company itself highlights that it sold 42 apartments in 2025 through contractor-loan structures, with gross volume of NIS 101.5 million, and financing costs of NIS 4.488 million deducted from revenue. That does not mean the sales are fake. It does mean that anyone trying to read pricing and sales pace without looking at the cost of financing to the end buyer is getting a view that is too optimistic.

That is a material point for this sector. In a period where rates are still high and demand is not perfectly clean, growth driven through generous financing terms is not the same as normal growth. It helps preserve volume, but it pushes part of the economic cost into the margin. In Elbit Imaging’s case, that matters even more because the company is still building its capital base and does not yet have much room for error.

Competition here matters less than execution and funding access

There is no obvious classical moat here in the form of a dominant brand, unique land bank, or a structural edge against large developers. The current advantage is being built through organization speed, wide geographic spread, and access to financing. The report also shows no stated dependence on a single supplier across the entire group, but there are pockets of project-level concentration. The Kiryat Bialik contractor represented 31% of period purchases, and in Ben Shemen the execution contractor, which is also a project partner, represented 14% of purchases. That is not automatically a red flag, but it is a reminder that in residential development the quality of outcome depends on managing contractors and partners well, not just on selling apartments.

Cash Flow, Debt, and Capital Structure

This is the place where one framing matters more than any other: all-in cash flexibility. That is the correct bridge for Elbit Imaging because the central question is not how much theoretical value sits in the portfolio, but how much real financing room remains after actual cash uses.

Operating cash flow was positive at NIS 6.8 million in 2025. That matters, but the source matters too. Alongside the net loss, the company also recorded a NIS 2.9 million increase in customer advances and a NIS 3.1 million decline in contract assets. So part of the improvement came from pulling cash forward, not only from a mature business that is already self-funding.

On the other side, investing cash flow consumed NIS 47.9 million. Most of that came from NIS 37.6 million of loans to related companies, a NIS 7 million loan to Elbit Megoorim before the acquisition, acquisition-related payments, and a NIS 5.7 million increase in restricted cash in project financing accounts. That is exactly the difference between a company that looks attractive because of its project pipeline and a company that is already generating true free cash.

The meaning is straightforward. Operations contributed, but did not fund the rate of expansion. The company needed the capital markets and debt to keep moving, and year-end cash still fell from NIS 39.9 million to NIS 26.8 million.

The working-capital deficit is not necessarily distress, but it should not be waved away

At December 31, 2025, the company reported a working-capital deficit of NIS 18.2 million. On a 12-month basis, the number is even more negative at NIS 40.1 million. Management explains that the main driver is classification: land in projects such as Afula and Tamarim Eilat sits in non-current assets, while the related borrowing, roughly NIS 58 million in total, sits in short-term liabilities. Under the assumption that those loans are extended or rolled into project bank financing, management says working capital becomes positive by roughly NIS 40 million, and the 12-month working-capital view becomes positive by about NIS 18 million.

That argument is reasonable, but it is important not to confuse “not a formal warning sign” with “no refinancing dependence.” In practice, the thesis depends on permits actually arriving, banks actually putting project financing in place, and capital markets staying open. This is not a distress case, but it is not balance-sheet comfort either.

Debt is better structured, but not free

At year-end 2025 the company had NIS 171.9 million of short-term bank and other debt, NIS 59.1 million of Series Y bonds, and NIS 11.5 million of other long-term debt. Against that stood NIS 26.8 million of cash and cash equivalents, plus about NIS 3 million of marketable securities. Equity-to-balance-sheet stood at 23.5% for Series Y and 26% for Series XI, well above the 13% minimum, while equity itself stood at NIS 78 million excluding minority interests and NIS 87 million including minority interests, again above the covenant floors.

This is why the phrase “strong balance sheet” is still too generous. There is equity, and there is covenant headroom, but liabilities remain heavy relative to cash. So the decisive variable is the pace at which projects mature, not merely the fact that technical covenant tests are currently being met.

Value is being created, but not all of it is accessible

Kiryat Bialik is the best example. On one hand, 173 units were already sold by year-end 2025, and the partner agreed to reset the rate on its project-level equity loan to 8% instead of the step-up structure that could have reached 12%. On the other hand, in January 2026 the partner completed a NIS 120 million bond raise secured by the full project surplus. The company notes that if, for any reason, the surplus is not transferred to it directly, the partner is obligated to pass the amount on. But that is exactly the point. A project can improve while the path from project value to free shareholder cash still becomes more structured and more conditional.

Outlook

Before getting into the detail, there are four non-obvious conclusions worth stating up front:

1. 2026 looks more like a bridge year with proof points than a breakout year.
2. The next triggers are not mainly accounting events, but permits, presales, financing openings, and bond-proceeds release conditions.
3. The large portfolio numbers in the presentation describe a multi-year option value, not cash that is already free for common shareholders.
4. If the weak selling environment seen at the start of 2026 persists, even projects that look close may slip without the pipeline itself appearing damaged on paper.

What has to happen for the read to improve

First, Afula needs to move from financing-on-paper into actual execution. Under the financing agreement, construction must begin by May 30, 2026, alongside a presale target of 40 units worth NIS 71.4 million. If the company clears that gate, it will be the first hard sign that the new financing layer is not just refinancing expensive debt but actually converting the pipeline into execution.

Second, Herzog 3 needs to move from permit to construction. The full permit was already received on February 12, 2026, with expected revenue of about NIS 86 million and expected gross profit of about NIS 17 million. Because that permit is also tied to the release of part of the Series XI proceeds, progress there will tell the market something about funding access as well as project execution.

Third, the market will watch Bialik closely. The March 2026 amendment opened larger financing capacity, but it also required NIS 277.8 million of presales for Phase B and a final permit for Phase A2 by April 30, 2026. If those conditions are met, Bialik becomes a project that can genuinely lower reliance on expensive capital. If not, the company remains with a very attractive theoretical project and an unresolved execution bottleneck.

The future-surplus map already looks impressive, but it needs to be handled carefully

In the January 2026 presentation, the company lays out expected surplus by project on a company-share basis. The numbers look extremely strong relative to the current market cap, and that is exactly where discipline matters most. The distinction is not between “large” and “small.” It is between value that exists in the project model and value that is already accessible to shareholders.

What matters is not that the bars are tall. It is that most of that money is still not free. Some of it is subordinated to banks, some of it sits inside equity-accounted companies, some of it still requires presales, and some of it will only arrive in 2027 through 2030. So the right comparison is not between future surplus and today’s market cap. It is between future surplus and the time, equity, and execution discipline required to reach it.

The urban-renewal option is expanding, but so is dilution risk

The Zionut transaction, approved in February 2026, is a clean example of that duality. On one hand, it adds another Jerusalem urban-renewal project, and the presentation attributes NIS 536 million of expected revenue, NIS 132 million of gross profit, and NIS 113 million of expected surplus to the company’s share there. On the other hand, it is being paid for through the issuance of 2,705,444 shares, it depends on 80% of owners in the site and 60% in each building signing, and it will lift controlling-shareholder voting power above 45%. So the pipeline expands, but capital-allocation complexity expands with it.

That is why 2026 looks like a bridge year with proof points. If the company can show financing openings, construction starts, presales, and further income-statement recognition without again leaning heavily on expensive short-term debt or additional equity dilution, the read can improve fast. If not, Elbit Imaging will stay in the familiar place of having substantial option value on paper, too little free cash, and too many milestones still waiting to be proven.

Risks

Demand could soften exactly when the company needs presale milestones. The company itself says 2026 began with a meaningful slowdown in apartment sales, mainly because of the security situation, and notes that it cannot yet assess how the housing market and demand will evolve through the rest of the year. In Afula and Bialik, that is not a generic macro point. It is a direct financing condition.

Refinancing and permit timing still stand ahead of shareholder cash. The working-capital deficit is not flagged as a warning sign, but it still depends on the assumption that land loans will be rolled or folded into bank project financing. If one of the permit or sales milestones slips, the pressure on the funding layer does not disappear.

Sales supported by contractor loans reduce margin quality. In 2025, 42 apartments were sold using that structure, and financing costs of NIS 4.488 million were deducted from revenue. If the selling environment remains weak, the pressure to preserve volume with buyer financing support may continue.

The legacy overhang has not disappeared. Casa Radio in Romania is not part of the current operating thesis, but it remains part of the stock’s risk profile. The company reports a claim of about EUR 1.5 billion, with no provision and still at an early stage. Even if management rejects the allegations entirely, this is an external risk that the market cannot ignore.

Dilution is part of the business model. The February 2026 equity raise and the Zionut share issuance show that the company is not trying to build itself through debt alone. That is healthier on one level, but it also means existing shareholders need to assume that additional equity may still be used when projects require fresh capital.

Low liquidity is itself a risk. When the stock trades only a few hundred thousand shekels a day, even good news can take too long to translate into price, while bad news can weigh disproportionately.

Conclusions

Elbit Imaging entered 2025 as a company that still needed to prove it actually had a business. It exits the year with a real project pipeline, operating activity, public-market funding, and projects that are beginning to reach reported numbers. What still blocks a cleaner thesis is that the key link, converting pipeline into recognized earnings and free cash, has not yet been proven at sufficient speed. In the short to medium term, the market is likely to react less to the 2025 headline numbers and more to whether Afula, Herzog 3, and Bialik actually clear the financing and presale hurdles already laid out for them.

Current thesis: Elbit Imaging has already built the base of a residential developer, but it has not yet proven that project-level value can rise at a fast enough pace to the common-shareholder layer.

What changed versus the old read: 2025 moved the story from pipeline and promise into a stage where there is now accounting recognition, public debt, new permits, and concrete financing frameworks.

Strong counter-thesis: The market may still be anchoring too heavily on the legacy baggage and current-period losses, and in doing so may be underestimating the gap between current market cap and the project pipeline, expected surplus, and lower financing cost structure.

What could change the market’s read soon: Hitting the financing and presale milestones in Afula and Bialik, moving Herzog 3 into execution, and repeating the fourth-quarter operating improvement without leaning even harder on customer financing or new equity issuance.

Why this matters: This is a test of whether a newly built residential-development platform can turn permits, partnerships, and public debt into recognized earnings, released surplus, and cheaper funding, or whether the value will remain mostly trapped on paper.

If, over the next 2 to 4 quarters, the company opens financing, starts execution, hits presale thresholds, and shows that fourth-quarter profitability was not a one-off, the read can improve materially. If those milestones slip, Elbit Imaging will remain in the uncomfortable gap between attractive presentation-level value and a still-narrow cash layer.